Curtis R Pickering Selected Research

Curtis R Pickering Research Topics

Disease

38	Neoplasms (Cancer) 04/2024 - 11/2006
27	Squamous Cell Carcinoma of Head and Neck 10/2023 - 07/2011
9	Head and Neck Neoplasms (Head and Neck Cancer) 10/2023 - 09/2013
7	Mouth Neoplasms (Oral Cancer) 01/2022 - 11/2015
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 07/2011
3	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2019
3	Carcinogenesis 08/2021 - 03/2005
2	Inflammation (Inflammations) 01/2024 - 01/2018
2	Bites and Stings (Sting) 01/2024 - 01/2022
2	Lung Neoplasms (Lung Cancer) 12/2023 - 07/2023
2	Retinoblastoma (Glioblastoma, Retinal) 10/2022 - 11/2006
2	Communicable Diseases (Infectious Diseases) 11/2021 - 01/2021
2	COVID-19 11/2021 - 01/2021
1	Chromosomal Instability (Chromosome Stability) 01/2024
1	Exanthema (Rash) 04/2022
1	Infections 01/2022
1	Carcinoma (Carcinomatosis) 01/2019
1	Thymoma (Thymic Carcinoma) 12/2018
1	Autoimmune Diseases (Autoimmune Disease) 12/2018
1	Aneuploidy (Aneuploid) 12/2018
1	Myasthenia Gravis 12/2018
1	Hematologic Neoplasms (Hematological Malignancy) 04/2018
1	Bone Marrow Failure Disorders 04/2018
1	Leukemia 04/2018
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Sarcoma (Soft Tissue Sarcoma) 01/2014
1	Polyps 01/2014
1	Adenocarcinoma 01/2014
1	Colonic Neoplasms (Colon Cancer) 01/2014
1	Starvation 07/2011
1	Neoplastic Processes 03/2005

Drug/Important Bio-Agent (IBA)

16	Biomarkers (Surrogate Marker)IBA 04/2024 - 03/2013
9	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2014
6	Proteins (Proteins, Gene)FDA Link 01/2024 - 02/2012
4	MicroRNAs (MicroRNA)IBA 01/2020 - 09/2013
4	Phosphotransferases (Kinase)IBA 10/2018 - 09/2013
3	Tyrosine Kinase InhibitorsIBA 12/2023 - 11/2014
3	Cisplatin (Platino)FDA LinkGeneric 11/2022 - 09/2013
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2014
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 09/2013
2	InterferonsIBA 01/2024 - 01/2022
2	PlatinumIBA 10/2023 - 04/2015
2	Aurora KinasesIBA 10/2022 - 01/2018
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2022 - 11/2014
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
2	Membrane Proteins (Integral Membrane Proteins)IBA 11/2021 - 01/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2024
1	Docetaxel (Taxotere)FDA Link 11/2022
1	Oncogene Proteins (Oncogene Protein)IBA 10/2022
1	Retinoblastoma ProteinIBA 10/2022
1	Enhancer RNAsIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	16S Ribosomal RNAIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	UbiquitinIBA 01/2022
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 11/2021
1	mu Opioid Receptors (mu Opioid Receptor)IBA 08/2021
1	Opioid Analgesics (Opioids)IBA 08/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	niraparibIBA 01/2021
1	Caspase 8 (Caspase-8)IBA 12/2020
1	birinapantIBA 12/2020
1	TNF Receptor-Associated Factor 3IBA 12/2020
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2020
1	MTOR InhibitorsIBA 01/2019
1	AutoantigensIBA 12/2018
1	danusertibIBA 01/2018
1	Transforming Growth Factor-beta Type II ReceptorIBA 01/2018
1	HLA-A Antigens (HLA-A)IBA 01/2018
1	adavosertibIBA 11/2017
1	Vorinostat FDA Link 11/2017
1	Polo-Like Kinase 1IBA 01/2017
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2014
1	hydrogen sulfite (bisulfite)IBA 01/2014
1	MethyltransferasesIBA 01/2014
1	Bile Acids and Salts (Bile Acids)IBA 01/2014
1	3- (carbamoylamino)- 5- (3- fluorophenyl)- N- (3- piperidyl)thiophene- 2- carboxamideIBA 09/2013
1	Histone Deacetylase InhibitorsIBA 03/2013
1	Histone Deacetylases (Histone Deacetylase)IBA 03/2013
1	Glutamine (L-Glutamine)FDA Link 07/2011
1	Deoxyglucose (2 Deoxy D glucose)IBA 07/2011
1	Glucose (Dextrose)FDA LinkGeneric 07/2011
1	Cyclin-Dependent Kinase Inhibitor p16IBA 11/2006
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 11/2006
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2005

Therapy/Procedure

15	Therapeutics 10/2023 - 12/2011
7	Radiotherapy 01/2022 - 02/2012
2	Drug Therapy (Chemotherapy) 10/2023 - 10/2021
2	Chemoradiotherapy 11/2022 - 10/2021
1	Induction Chemotherapy 04/2022
1	Neoadjuvant Therapy 04/2022
1	Immunotherapy 01/2021
1	Hematopoietic Stem Cell Transplantation 04/2018
1	Aftercare (After-Treatment) 09/2016